Benzinga | Jun 16, 2021 04:16PM EDT

ClearPoint Neuro Highlights Installation Of ClearPoint 2.0 Software At Mazowiecki Szpital Brodnowski In Poland

ClearPoint Neuro, Inc. (NASDAQ:CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its version 2.0 software at Mazowiecki Szpital Br?dnowski in Warsaw, Poland.

"We appreciated the patience and commitment of the on-site ClearPoint team throughout the installation process," stated Professor Mirosaw Zbek, Head of the Neurosurgery Clinic at Mazowiecki Szpital Br?dnowski. "Our entire team is looking forward to begin performing DBS, biopsy and clinical trial cases with the ClearPoint Neuro Navigation System."

"Dr. Zbek and his team have been involved in cutting-edge drug delivery protocols for many years," commented Matt Rabon, Clinical and Business Development Manager, EMEA. "Poland is one of the largest clinical trial markets in Central Eastern Europe with highly qualified investigators and specialized medical centers. It will be a great honor to support both clinical procedures and investigational trials at this prestigious hospital. This is another example of us executing our strategy to set up ClearPoint biologic and drug delivery trial centers across Europe. Now that COVID seems to be receding in Europe, we expect these installations to continue in the second half of 2021."